These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26094833)

  • 1. A survey of UK practice patterns in the delivery of intravitreal injections.
    Samia-Aly E; Cassels-Brown A; Morris DS; Stancliffe R; Somner JE
    Ophthalmic Physiol Opt; 2015 Jul; 35(4):450-4. PubMed ID: 26094833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of an expert survey on VEGF inhibitors in ophthalmology].
    Kühn T
    Klin Monbl Augenheilkd; 2011 Jul; 228(7):607-12. PubMed ID: 21472638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of Victorian ophthalmologists who use ranibizumab to treat age-related macular degeneration: to identify current practice and modifiable risk factors relevant to post-injection endophthalmitis.
    Buck DA; Dawkins R; Kawasaki R; Sandhu SS; Allen PJ
    Clin Exp Ophthalmol; 2015 Apr; 43(3):277-9. PubMed ID: 25112536
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience of New Brunswick ophthalmologists using intravitreal anti-vascular endothelial growth factor.
    Giberson M; Taylor V
    Can J Ophthalmol; 2015 Oct; 50(5):393-4. PubMed ID: 26455977
    [No Abstract]   [Full Text] [Related]  

  • 5. Survey of intravitreal injection techniques and treatment protocols among retina specialists in Canada.
    Xing L; Dorrepaal SJ; Gale J
    Can J Ophthalmol; 2014 Jun; 49(3):261-6. PubMed ID: 24862772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey: technique of performing intravitreal injection among members of the Brazilian Retina and Vitreous Society (SBRV).
    Shiroma HF; Farah ME; Takahashi WY; Gomes AM; Goldbaum M; Rodrigues EB
    Arq Bras Oftalmol; 2015; 78(1):32-5. PubMed ID: 25714535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal injections: is there benefit for a theatre setting?
    Abell RG; Kerr NM; Allen P; Vote BJ
    Br J Ophthalmol; 2012 Dec; 96(12):1474-8. PubMed ID: 23018424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GMC is criticised for refusing to disclose reasons behind its advice to support prescribing for Lucentis rather than Avastin for wet AMD.
    Cohen D
    BMJ; 2015 Apr; 350():h1981. PubMed ID: 25869865
    [No Abstract]   [Full Text] [Related]  

  • 9. Off-label prescribing in macular degeneration.
    McCartney M
    BMJ; 2011 Oct; 343():d6778. PubMed ID: 22012651
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis.
    Campbell RJ; Bronskill SE; Bell CM; Paterson JM; Whitehead M; Gill SS
    Arch Ophthalmol; 2010 Mar; 128(3):359-62. PubMed ID: 20212208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Trends in Intravitreal Injection Practices among American Retina Specialists.
    Chaturvedi R; Wannamaker KW; Riviere PJ; Khanani AM; Wykoff CC; Chao DL
    Ophthalmol Retina; 2019 Aug; 3(8):656-662. PubMed ID: 31133544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
    Yannuzzi NA; Patel SN; Bhavsar KV; Sugiguchi F; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):319-327.e2. PubMed ID: 24814167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal macular electroretinograms after intravitreal injections of bevacizumab for age-related macular degeneration.
    Iwata E; Ueno S; Ishikawa K; Ito Y; Uetani R; Piao CH; Kondo M; Terasaki H
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4185-90. PubMed ID: 22618591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injections: a review of the evidence for best practice.
    Fagan XJ; Al-Qureshi S
    Clin Exp Ophthalmol; 2013 Jul; 41(5):500-7. PubMed ID: 23078366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic regression patterns after intravitreal ranibizumab injections for neovascular age-related macular degeneration.
    Tran TH; Querques G; Forzy G; Souied EH
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):498-508. PubMed ID: 21830744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.
    Hasler PW; Bloch SB; Villumsen J; Fuchs J; Lund-Andersen H; Larsen M
    Acta Ophthalmol; 2015 Mar; 93(2):122-5. PubMed ID: 25403735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimanual assisted eyelid retraction technique for intravitreal injections.
    Fineman MS; Hsu J; Spirn MJ; Kaiser RS
    Retina; 2013 Oct; 33(9):1968-70. PubMed ID: 23609121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microperimetric changes after intravitreal bevacizumab injection for exudative age-related macular degeneration.
    Ozdemir H; Karacorlu M; Senturk F; Karacorlu SA; Uysal O
    Acta Ophthalmol; 2012 Feb; 90(1):71-5. PubMed ID: 20163371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Azithromycin in prophylaxis of intravitreal injections in patients with wet age-related macular degeneration].
    Figurska M
    Klin Oczna; 2011; 113(1-3):38-41. PubMed ID: 21853949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for exudative age-related macular degeneration in clinical practice.
    Jonas JB; Tao Y; Schlichtenbrede FC
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):467-70. PubMed ID: 21682590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.